Fermer le menu

Member of Lyonbiopole


Development of antivirals for HIV and EBV infections. Main objective is the control of the HIV-1 reservoir allowing a functional cure with cessation of the antiretroviral therapy. The second objective is the prevention of EBV-induced post transplant lymphoproliferative diseases.


Strategic application domain: Human Medicine

Application market: Hematology, Infectious Diseases, Oncology

Type of activity: Therapeutics, Pharma or Biotech

Technologies: Small Molecules

Created on oct. 9th, 2020 - 2 employees



321 avenue Tony Garnier 69007 Lyon



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.